HCM
TAK icon

Highlander Capital Management’s Takeda Pharmaceutical TAK Stock Holding History

Highlander Capital Management’s Portfolio TAK Stock Details TAK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		$29.8K Hold
2,144
– – 0.01% 476
2023
Q4 		$30.6K Hold
2,144
– – 0.01% 471
2023
Q3 		$33K Buy
+2,144
New +$33.2K 0.01% 430

Other funds holding TAK

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
MIP
Mondrian Investment Partners London, United Kingdom $6.69B AUM
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BIP
Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Highlander Capital Management's TAK Position: Q1 2024 in Review

Highlander Capital Management held its Takeda Pharmaceutical (TAK) position steady in Q1 2024 at 2,144 shares worth $29.8K. The position accounts for 0.01% of the portfolio, ranked #476.

Highlander Capital Management first reported a position in TAK in Q3 2023 and has held it in 3 quarters since. The position peaked at $33K in Q3 2023. 313 funds tracked by Wall St. Rank hold TAK as of Q1 2024.

  • Highlander Capital Management held 2,144 shares of Takeda Pharmaceutical worth $29.8K as of Q1 2024.
  • Highlander Capital Management left its Takeda Pharmaceutical share count unchanged in Q1 2024.
  • Takeda Pharmaceutical made up 0.01% of Highlander Capital Management's portfolio in Q1 2024, its #476 holding.
  • Highlander Capital Management first reported a position in Takeda Pharmaceutical in Q3 2023 and has held it in 3 quarters since.
  • Highlander Capital Management's Takeda Pharmaceutical position peaked at $33K in Q3 2023.
  • 313 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q1 2024.

Based on Highlander Capital Management's 13F filing for Q1 2024, filed 20 May 2024.